ZENAS BIOPHARMA

Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO

The company expects its shares to trade on the Nasdaq Global Market under the ticker symbol 'ZBIO'. Morgan Stanley, Jefferies, Citigroup and Guggenheim Securities are the underwriters.